Nicole Eter

Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials

Jeffrey S. Heier, Eleonora M. Lad, Frank G. Holz et al. · The Lancet · 2023 · 372 citations

Ocular Disease, Ophthalmology, Age-related Diseases +4

Intraocular Pharmacokinetics of Bevacizumab After a Single Intravitreal Injection in Humans

Tim U. Krohne, Nicole Eter, Frank G. Holz et al. · American Journal of Ophthalmology · 2008 · 361 citations

Vitreous Body, Ophthalmology, Intraocular Pharmacokinetics +4

Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial

Arshad M. Khanani, Sunil Patel, Giovanni Staurenghi et al. · The Lancet · 2023 · 263 citations · Full text

Clinical Epidemiology, Clinical Trials, Geographic Atrophy +5

Automated detection of exudative age-related macular degeneration in spectral domain optical coherence tomography using deep learning

Maximilian Treder, Jost Lennart Lauermann, Nicole Eter · Graefe s Archive for Clinical and Experimental Ophthalmology · 2017 · 238 citations

Ocular Disease, Engineering, Retina +9

Human RPE Stem Cells Grown into Polarized RPE Monolayers on a Polyester Matrix Are Maintained after Grafting into Rabbit Subretinal Space

Boris V. Stanzel, Zengping Liu, Sudawadee Somboonthanakij et al. · Stem Cell Reports · 2014 · 168 citations · Full text